However, given the involvement of inflammasomes in DNA damage responses induced by cellular stress [35], persistently elevated levels of soluble p53 might also reflect enhanced inflammatory or otherwise immunogenic programmed cell death rates in low-risk MDS patients not responding to asunercept in our series. The gene discussed is TP53; the disease is myelodysplastic syndrome.